Rodman David Malcom — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Rodman David Malcom has filed 7 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $5.99M.

Profile

Rodman David Malcom

David Malcom Rodman is the Chief Medical Officer at Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for diseases related to elevated aldosterone levels. He has been involved in multiple SEC filings related to his role at the company.

RoleChief Medical Officer
Notability30/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-07-16MLYSMineralys Therapeutics, Inc.S — Open-market sale [10b5-1]6.3K$26.61$169K
2026-07-16MLYSMineralys Therapeutics, Inc.S — Open-market sale [10b5-1]14.1K$27.58$388K
2026-07-16MLYSMineralys Therapeutics, Inc.M — Option exercise [10b5-1]6.3K$1.08$7K
2026-07-16MLYSMineralys Therapeutics, Inc.M — Option exercise [10b5-1]4.2K$14.25$59K
2026-07-16MLYSMineralys Therapeutics, Inc.M — Option exercise [10b5-1]3.5K$10.20$36K
2026-07-10MLYSMineralys Therapeutics, Inc.S — Open-market sale2.2K$30.30$66K
2026-07-10MLYSMineralys Therapeutics, Inc.M — Option exercise2.2K$16.00$35K
2026-06-18MLYSMineralys Therapeutics, Inc.S — Open-market sale4.6K$25.00$115K
2026-06-18MLYSMineralys Therapeutics, Inc.M — Option exercise417$15.44$6K
2026-06-18MLYSMineralys Therapeutics, Inc.M — Option exercise4.2K$14.25$59K
2026-06-18MLYSMineralys Therapeutics, Inc.S — Open-market sale9.9K$23.81$235K
2026-06-18MLYSMineralys Therapeutics, Inc.M — Option exercise3.5K$10.20$36K
2026-06-12MLYSMineralys Therapeutics, Inc.S — Open-market sale6.3K$23.93$152K
2026-06-12MLYSMineralys Therapeutics, Inc.M — Option exercise6.3K$1.08$7K
2026-06-12MLYSMineralys Therapeutics, Inc.S — Open-market sale2.2K$25.00$54K
2026-06-12MLYSMineralys Therapeutics, Inc.M — Option exercise2.2K$16.00$35K
2026-05-19MLYSMineralys Therapeutics, Inc.S — Open-market sale417$27.55$11K
2026-05-19MLYSMineralys Therapeutics, Inc.M — Option exercise417$15.44$6K
2026-05-14MLYSMineralys Therapeutics, Inc.S — Open-market sale14.1K$28.58$402K
2026-05-14MLYSMineralys Therapeutics, Inc.M — Option exercise4.2K$14.25$59K

Companies — Last 90 Days

Frequently Asked Questions

Who is Rodman David Malcom?

David Malcom Rodman is the Chief Medical Officer at Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for diseases related to elevated aldosterone levels. He has been involved in multiple SEC filings related to his role at the company.…

How many SEC Form 4 filings has Rodman David Malcom submitted recently?

7 primary Form 4 filings in the last 90 days, covering 1 company.

Has Rodman David Malcom been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 38 open-market sales ($5.99M) across all tracked filings.

Where can I see all of Rodman David Malcom's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Rodman David Malcom profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.